
Kiyatec
Developer of a 3D cell culture technology designed to predict patient response to therapies before the treatment begins. The company's technology utilizes patients' own living tumor cells to create ph...
Valuation
$0
Share Price
N/A
Total Raised
$32.4M
Last Round
N/A